According to MarketsandMarkets™, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

Genomic sequencing has come a long way in a short time, and its potential to drive even faster innovations in precision medicine is enormous. To capitalize on that opportunity, however, health systems ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...